Observational studyBMC cancer2019

Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO).

Javier Puente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.